1-methyltryptophan has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, M; Feng, LL; Gao, JM; Ge, XL; Liu, XQ; Lu, K; Wang, X | 1 |
Goto, N; Hara, T; Ito, H; Kochi, T; Kubota, M; Mabuchi, R; Moriwaki, H; Nagano, J; Nakamura, N; Ohno, T; Saito, K; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H | 1 |
2 other study(ies) available for 1-methyltryptophan and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration.
Topics: Adult; Aged; Aged, 80 and over; Animals; Blotting, Western; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Female; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interleukin-2 Receptor alpha Subunit; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Mice; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes, Regulatory; Tryptophan; Up-Regulation; Young Adult | 2014 |
Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.
Topics: Animals; Cyclophosphamide; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasms, Experimental; T-Lymphocytes, Regulatory; Tryptophan | 2015 |